| Secondary |
| Hypertension |
19.4% |
| Product Used For Unknown Indication |
15.3% |
| Acute Coronary Syndrome |
10.2% |
| Diabetes Mellitus |
6.1% |
| Blood Cholesterol Increased |
5.1% |
| Cardiac Disorder |
4.1% |
| Maternal Drug Exposure |
4.1% |
| Maternal Exposure Timing Unspecified |
4.1% |
| Anticoagulant Therapy |
3.1% |
| Blood Pressure |
3.1% |
| Emphysema |
3.1% |
| Glaucoma |
3.1% |
| Myocardial Infarction |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Vitiligo |
3.1% |
| Blood Cholesterol Abnormal |
2.0% |
| Diabetes Mellitus Management |
2.0% |
| Exposure During Pregnancy |
2.0% |
| Hypothyroidism |
2.0% |
| Infarction |
2.0% |
|
| Poor Quality Drug Administered |
12.9% |
| Vomiting |
9.7% |
| Drug Abuse |
6.5% |
| Haemoglobin Decreased |
6.5% |
| Hypertension |
6.5% |
| Respiratory Disorder Neonatal |
6.5% |
| Venous Occlusion |
6.5% |
| Wound |
6.5% |
| Arrhythmia |
3.2% |
| Asthma |
3.2% |
| Coronary Artery Occlusion |
3.2% |
| Death |
3.2% |
| Foetal Exposure During Pregnancy |
3.2% |
| Gastrointestinal Infection |
3.2% |
| Hypersensitivity |
3.2% |
| Malaise |
3.2% |
| Oedema Peripheral |
3.2% |
| Premature Baby |
3.2% |
| Respiratory Arrest |
3.2% |
| Septic Shock |
3.2% |
|
| Concomitant |
| Hypertension |
23.3% |
| Product Used For Unknown Indication |
13.0% |
| Diabetes Mellitus |
9.8% |
| Cardiac Disorder |
9.0% |
| Rheumatoid Arthritis |
7.0% |
| Anticoagulant Therapy |
5.1% |
| Type 2 Diabetes Mellitus |
3.8% |
| Prophylaxis |
3.2% |
| Blood Cholesterol |
3.1% |
| Drug Use For Unknown Indication |
2.8% |
| Depression |
2.7% |
| Osteoporosis |
2.6% |
| Blood Pressure |
2.5% |
| Blood Cholesterol Increased |
2.4% |
| Gastric Disorder |
1.8% |
| Pain |
1.7% |
| Blood Disorder |
1.7% |
| Dementia Alzheimer's Type |
1.7% |
| Emphysema |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
10.7% |
| Weight Decreased |
8.6% |
| Venous Occlusion |
7.4% |
| Pneumonia |
6.1% |
| Urinary Tract Infection |
6.1% |
| Weight Increased |
5.7% |
| Tremor |
5.3% |
| Syncope |
4.9% |
| Visual Impairment |
4.9% |
| Infarction |
4.5% |
| Cerebrovascular Accident |
4.1% |
| Pain In Extremity |
4.1% |
| Respiratory Failure |
4.1% |
| Renal Failure |
3.7% |
| Vision Blurred |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Memory Impairment |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Hypoglycaemia |
2.9% |
| Nervous System Disorder |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
63.3% |
| Arrhythmia |
10.0% |
| Plasma Cell Myeloma |
6.7% |
| Atrial Fibrillation |
3.3% |
| Cerebrovascular Accident Prophylaxis |
3.3% |
| Hyperlipidaemia |
3.3% |
| Hypertension |
3.3% |
| Hypothyroidism |
3.3% |
| Myocardial Ischaemia |
3.3% |
|
| Drug Interaction |
50.0% |
| Cardio-respiratory Arrest |
25.0% |
| Pruritus |
25.0% |
|
